Search Results - Elise Tu
- Showing 1 - 2 results of 2
-
1
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study by Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews
Published in JHEP Reports (2023-10-01)Get full text
Article -
2
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study by Joanne M. Carson, Sebastiano Barbieri, Evan Cunningham, Eric Mao, Marc van derValk, Jürgen K. Rockstroh, Margaret Hellard, Arthur Kim, Sanjay Bhagani, Jordan J. Feld, Ed Gane, Maria C. Thurnheer, Julie Bruneau, Elise Tu, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, the REACT study group
Published in Journal of the International AIDS Society (2023-09-01)Get full text
Article
